Active Ingredient(s):Baloxavir Marboxil FDA Approved: * October 24, 2018 Pharm Company: *GENENTECH INC Category:Antiviral
Baloxavir marboxil (BXM), sold under the brand name Xofluza, is an antiviral medication for treatment of influenza A and influenza B flu. It was approved for medical use both in Japan and in the United States in 2018, and is taken as a single dose by mouth. It may reduce the duration of flu symptoms by about a day, but is prone to selection of resistant mutants that render it ineffectual.[7&...
* May have multiple approval dates, manufacturers, or labelers.